p53 immunoreactivity in Barrett's metaplasia, dysplasia, and adenocarcinoma - A case report

Hepato-Gastroenterology

Volumn 48, Issue 42, 2001, Pages 1662-1664

  Kimura, H ^a   Konishi, K ^a   Kaji, M ^a   Maeda, K ^a   Yabushita, K ^a   Miwa, A ^a  

^a Dept of Surg Yamanaka Natl Hosp ^*  (Japan)

Author keywords

Barrett's esophagus; Malignant potential; Metaplasia dysplasia carcinoma sequence

Indexed keywords

MONOCLONAL ANTIBODY; MUTANT PROTEIN; PROTEIN P53;

ADENOCARCINOMA; AGED; ARTICLE; BARRETT ESOPHAGUS; CASE REPORT; DYSPLASIA; ESOPHAGUS CARCINOMA; ESOPHAGUS DISEASE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; EPITHELIUM; ESOPHAGEAL NEOPLASMS; FATAL OUTCOME; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUTATION;

EID: 0035658659     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Epidemiology of gastroesophageal reflux disease
2. Adenocarcinoma and Barrett's esophagus. An overrated risk?
3. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus
4. Barrett's esophagus: Comparison of benign and malignant cases
5. The relationship between gastroesophageal reflex disease and its complications with Barrett's esophagus
6. Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies
7. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: A pathological study
8. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy
9. p53 gene mutation in Barrett's epithelium and esophageal cancer
10. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry
11. Potential application of p53 as an intermediate biomarker in Barrett's esophagus
12. p53 Immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma
13. Oncogene activation in esophageal cancer